Detalles de la búsqueda
1.
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial.
Clin Infect Dis
; 57 Suppl 2: S90-6, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23884072
2.
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
Lancet Gastroenterol Hepatol
; 8(6): 533-552, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996853
3.
Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs.
Can Liver J
; 3(3): 276-285, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992530
4.
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study.
Can Liver J
; 3(4): 358-371, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35990509
5.
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C.
Can Liver J
; 3(3): 251-262, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992533
6.
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients.
CMAJ Open
; 6(1): E12-E18, 2018 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29305405
Resultados
1 -
6
de 6
1
Próxima >
>>